Camelia C.
- Country
- Romania
- Department
- Gastroenterology
Research Overview
- N1T-MC-MALO: A Master Protocol for a Randomized, Controlled, Clinical Trial of Multiple Pharmacologic Agents in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease Who Are at Increased Risk of Developing Major Adverse Liver Outcomes (SYNERGY-Outcomes); N1T-MC-TZ01 Tirzepatide in participants with high-risk MASLD; N1T-MC-RT01 Retatrutide in participants with high-risk MASLD
- Phase 2 Study of LY4268989 Co-administered with Mirikizumab in Adults with Moderately to Severely Active Ulcerative Colitis
- Long‑Term Safety and Efficacy of SPY001‑001 Monotherapy and Combination Therapy with Long‑Acting Antibodies in Adults with Ulcerative Colitis
Data & Insights
Has run more than one trial at 334 of 629 partner sites.
Specializations
Inflammatory Bowel Disease
Clinical activity is centered on ulcerative colitis and Crohn’s disease, with interest in both active disease control and longer-term maintenance of remission.
- Ulcerative colitis
- Crohn’s disease
- Endoscopic response
- Clinical remission
The therapeutic focus includes advanced gastroenterology care for persistent intestinal inflammation and treatment-resistant disease.
Systemic Autoimmune Disease
Research involvement extends to systemic lupus erythematosus, cutaneous lupus erythematosus, rheumatoid arthritis, psoriatic arthritis, and axial spondyloarthritis.
- Systemic lupus erythematosus
- Cutaneous lupus erythematosus
- Rheumatoid arthritis
- Psoriatic arthritis
These areas reflect a sustained therapeutic interest in immune-mediated disease activity, symptom burden, and control of chronic inflammatory flares.
Respiratory and Upper Airway Disorders
Clinical trial participation includes asthma, chronic rhinosinusitis with nasal polyps, and allergic rhinoconjunctivitis, alongside broader airway inflammation.
- Moderate-to-severe asthma
- Chronic rhinosinusitis with nasal polyps
- Allergic rhinoconjunctivitis
- Upper airway inflammation
The therapeutic emphasis is on controlling respiratory symptoms and reducing inflammatory disease activity affecting the nose and bronchi.
Cardiovascular and Metabolic Disease
Research interests include hypertension, atrial fibrillation, acute myocardial infarction, stable angina pectoris, and broader atherosclerotic cardiovascular disease.
- Hypertension
- Atrial fibrillation
- Acute myocardial infarction
- Atherosclerotic cardiovascular disease
Additional involvement in metabolic dysfunction-associated steatotic liver disease and elevated Lp(a) points to interest in cardiometabolic risk reduction.
Oncology and Urologic Oncology
The trial portfolio also covers non-small cell lung cancer, metastatic breast cancer, metastatic prostate cancer, colorectal cancer, and high-risk non-muscle-invasive bladder cancer.
- Non-small cell lung cancer
- Metastatic breast cancer
- Metastatic prostate cancer
- Bladder cancer
This area includes interest in solid tumor therapies across thoracic, gastrointestinal, and genitourinary oncology.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.